Changes in pyrophosphatase activity during the de novo mineralization associated with cartilage and bone formation.
Pyrophosphatase was extracted from implants undergoing de novo mineralization in an in vivo model of matrix-induced endochondral bone formation. Before the onset of the mineralization of the plaques and after the mineralization process had been completed only one form of pyrophosphatase activity was observed. During the active deposition of calcium phosphate, however, a new, higher molecular weight form of pyrophosphatase activity was produced suggesting that this enzyme activity is associated with biological mineralization. This observation gives support to the earlier suggestion that inhibitors of calcium phosphate precipitation, such as pyrophosphate, must be removed from the site of mineralization before calcification can occur. This high-molecular-weight activity also appears to be associated with alkaline and/or acid phosphatase activity as determined by molecular exclusion chromatography.
D000818:Animals; D001846:Bone Development; D001857:Bone Matrix / Q000201:enzymology* / Q000637:transplantation*; D002356:Cartilage / Q000201:enzymology*; D002413:Cations, Divalent; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008297:Male; D011755:Pyrophosphatases / Q000378:metabolism*; D051381:Rats; D014018:Tissue Distribution
D002413:Cations, Divalent; D011755:Pyrophosphatases